Developer docs
API playgroundTry for free, no card

Search company profiles

Ronovo Surgical

Full company profile

uuid00004gq

Namestring
Ronovo Surgical
Legal namestring
瑞龙诺赋(上海)医疗科技有限公司
Websiteurl
ronovo.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Ronovo Surgical (瑞龙外科/瑞龙诺赋) is a Shanghai-based medical technology company founded in November 2019 by Dr. Ma Changzheng (former Intuitive Surgical SVP) and Dr. Mao Ying (former Auris Health control algorithm lead) to develop modular, accessible laparoscopic surgical robots for the Chinese and global markets. Its flagship product, the Haishan-1 (海山一) modular laparoscopic surgical robot system, received NMPA market approval in March 2025 as China's first domestically developed modular surgical robot and the first surgical robot cleared for all four core specialties—general surgery, thoracic surgery, gynecology, and urology—upon initial registration. The platform's defining architectural feature is a split-type design that separates robotic arms into independently deployable mobile carts, enabling flexible OR layouts, a footprint of approximately 35 square meters, single-docking cross-quadrant procedures, and compatibility with both robotic wristed instruments and traditional straight-shaft laparoscopic tools.

The company generates revenue through sale of Haishan-1 robot systems to top-tier Chinese hospitals, recurring surgical instrument revenue (single-use wristed and reusable straight-shaft instruments), and clinical training services delivered through its Yangzhou global production base. Distribution combines direct enterprise sales to tier-3A hospitals and academic medical centers across major Chinese cities with a September 2025 strategic partnership with Johnson & Johnson MedTech that provides access to J&J's established hospital channel and clinical education infrastructure in China. International expansion is pursued through CE certification for Europe and ANVISA for Latin America, anchored by the RISE (Ronovo Institute for Surgical Excellence) clinical research center in Orlando, Florida and the first Latin American commercial deployment at Clinica Monterrico in Peru (April 2026).

The company has filed more than 200 patents, employs 300+ professionals (65%+ holding graduate or doctoral degrees), and has cumulatively raised over $100M across multiple funding rounds, with the September 2025 $67M Series D led by Johnson & Johnson Development Corporation marking the most recent capital event. Over 600 clinical surgeries have been completed across multiple specialties with a reported 100% trial success rate. The Yangzhou production base, operational since April 2025, provides designed annual capacity of 500 surgical robot systems and 500,000 surgical instrument sets.

Short descriptiontext

Ronovo Surgical is a Shanghai-based medtech company that develops and commercializes the Haishan-1 modular laparoscopic surgical robot system, serving top-tier hospitals across general surgery, urology, gynecology, and thoracic surgery applications in China and select international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
modular surgical robots, minimally invasive surgery, robotic-assisted surgery, laparoscopic surgical systems, surgical robotics
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAE
Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Surgical Robotics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Surgical Robot System Sales
TypeHardware Sales
Description

Sale of Haishan-1 modular surgical robot systems to hospitals, including configurable cart quantities and instrument sets

ronovo.com
2Surgical Instruments and Consumables
TypeHardware Sales
Description

Single-use wristed instruments and reusable straight-shaft instruments, with consumable revenue generated per procedure

ronovo.com
3Clinical Training and Services
TypeProfessional Services
Description

Training programs for surgeons and clinical support services through the Yangzhou global production base training center

ronovo.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1海山一® (Haishan-1 / Carina™)
Description

China's first approved modular/lump-separated (分体式) laparoscopic surgical robot system, cleared for General Surgery, Urology, Gynecology, and Thoracic Surgery. Features modular cart design, flexible arm configuration, and compatibility with both wristed and straight instruments.

ronovo.com
+2 more records
Core offering1 text field

Ronovo Surgical designs, manufactures, and commercializes the Haishan-1® modular laparoscopic surgical robot system, including its integrated 3D vision platform and surgical instrument portfolio, for sale to hospitals and medical centers. The company's modular split-type architecture enables flexible cart-based deployment of robotic arms across operating rooms, supporting minimally invasive procedures in general surgery, urology, gynecology, and thoracic surgery. Revenue is generated through system sales, recurring consumables (instruments), and clinical training services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 600+ successful clinical surgeries completed across 5 specialties as of end of 2025
+4 more records
Product overview1 text field

Ronovo Surgical offers a modular, platform-based product portfolio centered on the Haishan-1® modular laparoscopic surgical robot system. The core platform consists of independently deployable modular trolleys with robotic arms that can be flexibly configured (3–5 arms) per surgical specialty and procedure type, combined with a surgeon console, electronic hub, and instrument accessories. The product line is supplemented by the Haishan-1® laparoscopic vision system (integrating 4K 3D and ICG fluorescence imaging) and a suite of surgical instruments including wristed and straight-shaft options. An add-on remote surgery ecosystem enables cross-regional surgical mentoring and tele-operation. Together, these products constitute an integrated, modular surgical robotics platform designed to serve general surgery, thoracic surgery, gynecology, and urology.

Product and service4 records
1Haishan-1® Modular Laparoscopic Surgical Robot System (海山一®分体式腔镜手术机器人系统)
CategorySurgical Robotics / Modular Surgical Robot Platform
Description

China's first domestically developed modular laparoscopic surgical robot featuring a split, modular architecture that separates robotic arms into independent trolley units, allowing flexible positioning, variable arm counts (3–5 arms), and rapid redeployment across operating rooms. NMPA-approved for general surgery, thoracic surgery, gynecology, and urology, designed for hospitals seeking flexible and cost-effective robotic surgery platforms.

2Haishan-1® Laparoscopic Vision System (海山一®腔镜视觉系统)
CategorySurgical Imaging System
Description

Integrated imaging module for the Haishan-1 surgical robot platform, incorporating 4K resolution, 3D stereoscopic visualization, and ICG (indocyanine green) fluorescence imaging with real-time blood flow perfusion assessment, tumor margin analysis, and anatomical structure identification capabilities.

3Haishan-1® Surgical Instruments (海山一®手术器械)
CategorySurgical Instruments and Consumables
Description

Surgical instrument portfolio for the Haishan-1 platform including wristed instruments (8mm) with enhanced articulation and straight-shaft instruments (5mm) for cost-effective procedures. Compatible with traditional laparoscopic instruments and the modular robotic system; supports multiple surgical disciplines.

4Ronovo Surgical Remote Surgery Ecosystem (Remote Surgical Assistance Platform)
CategoryRemote Surgery / Tele-surgery Platform
Description

A remote surgery platform enabling remote digital surgical mentoring and tele-surgery capabilities, supporting mentor-guided operation modes and demonstration modes for cross-regional surgical skill transfer, with latency controlled within 20ms over standard broadband networks.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Clinica Monterrico, Peru
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-29
Description

First Latin America commercial deployment and training center establishment for Spanish-speaking surgeon training in modular robotic surgery.

ronovo.com
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2025-11-03
Description

Industry-education partnership for talent cultivation, clinical research collaboration, and curriculum development related to surgical robotics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-04
Description

Strategic collaboration signed September 2025 to combine Ronovo's Haishan-1 modular surgical robot platform with J&J MedTech's minimally invasive surgery expertise. Partnership targets offering comprehensive digital minimally invasive surgery solutions to healthcare institutions in China. This marks J&J's first strategic partnership with a domestic surgical robot company.

4扬州大学附属医院 (Yangzhou University Affiliated Hospital)
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2025-04-26
Description

Strategic cooperation signed for clinical research collaboration, talent development, and promotion of surgical robot clinical applications.

ronovo.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-19
Description

Partnership to establish RISE (Ronovo Institute for Surgical Excellence) international clinical research center in Orlando, leveraging AdventHealth's surgical training infrastructure.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2023-11-16
Description

First batch company to join GE Healthcare's largest 'Innovation Center' in Shanghai Zhangjiang, focusing on digital medical imaging integration with surgical robotics.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global incumbent in robotic-assisted surgery with the da Vinci platform. Direct competitor in laparoscopic/soft-tissue robotic surgery across the same four specialties (general, urology, gynecology, thoracic) that Ronovo targets, with a dominant installed base in tier-1 Chinese hospitals.

TypeDirect peer
Description

Chinese domestic competitor developing single-port and modular endoscopic surgical robots with NMPA approvals. Targets the same Chinese hospital market and minimally invasive surgery applications as Ronovo's Haishan-1.

TypeDirect peer
Description

Chinese surgical robotics company with NMPA-approved laparoscopic and orthopedic robot systems. Competes head-to-head in the Chinese modular/multi-port robotic surgery market against Ronovo.

TypeDirect peer
Description

Chinese laparoscopic surgical robot company with NMPA-cleared systems, commercial deployments in Chinese hospitals, and overlapping specialty indications. Closest direct peer in the China multi-port modular robot category.

TypeDirect peer
Description

UK-based developer of the Versius modular surgical robot — a small-form-factor, modular-cart design that competes on the same portability, footprint, and cost-flexibility thesis as Ronovo's Haishan-1, targeting global markets.

TypeBroad incumbent
Description

Global medtech incumbent developing the Hugo robotic-assisted surgery platform. Competes in laparoscopic robotic surgery worldwide and is partnering with Ronovo-adjacent stakeholders, shaping the competitive context for Ronovo's international expansion.

TypeBroad incumbent
Description

Strategic partner of Ronovo and a competitor via the Ottava general-surgery robotics platform. The dual relationship creates both a major distribution advantage and a channel-conflict risk for Ronovo's international expansion.

TypeEmerging player
Description

Korean developer of the Revo-i laparoscopic surgical robot with regulatory approvals in multiple countries. Comparable modular-style platform competing for emerging-market and Asian hospital customers in the same specialty segments.

TypeEmerging player
Description

U.S. developer of a next-generation robotic surgery platform using decoupled/portable architecture. Comparable in pursuing a fundamentally different form-factor and deployment model than monolithic incumbents, though still pre-commercial.

TypeBroad incumbent
Description

Global medtech incumbent with the Mako orthopedic surgical robot and an emerging presence in soft-tissue robotics. Relevant as a broad incumbent in surgical robotics that competes for hospital capital budgets and OR integration contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ronovo Surgical

Surgical Roboticsronovo.com

Ronovo Surgical is a Shanghai-based medtech company that develops and commercializes the Haishan-1 modular laparoscopic surgical robot system, serving top-tier hospitals across general surgery, urology, gynecology, and thoracic surgery applications in China and select international markets.

What Ronovo Surgical does

Ronovo Surgical (瑞龙外科/瑞龙诺赋) is a Shanghai-based medical technology company founded in November 2019 by Dr. Ma Changzheng (former Intuitive Surgical SVP) and Dr. Mao Ying (former Auris Health control algorithm lead) to develop modular, accessible laparoscopic surgical robots for the Chinese and global markets. Its flagship product, the Haishan-1 (海山一) modular laparoscopic surgical robot system, received NMPA market approval in March 2025 as China's first domestically developed modular surgical robot and the first surgical robot cleared for all four core specialties—general surgery, thoracic surgery, gynecology, and urology—upon initial registration. The platform's defining architectural feature is a split-type design that separates robotic arms into independently deployable mobile carts, enabling flexible OR layouts, a footprint of approximately 35 square meters, single-docking cross-quadrant procedures, and compatibility with both robotic wristed instruments and traditional straight-shaft laparoscopic tools.

The company generates revenue through sale of Haishan-1 robot systems to top-tier Chinese hospitals, recurring surgical instrument revenue (single-use wristed and reusable straight-shaft instruments), and clinical training services delivered through its Yangzhou global production base. Distribution combines direct enterprise sales to tier-3A hospitals and academic medical centers across major Chinese cities with a September 2025 strategic partnership with Johnson & Johnson MedTech that provides access to J&J's established hospital channel and clinical education infrastructure in China. International expansion is pursued through CE certification for Europe and ANVISA for Latin America, anchored by the RISE (Ronovo Institute for Surgical Excellence) clinical research center in Orlando, Florida and the first Latin American commercial deployment at Clinica Monterrico in Peru (April 2026).

The company has filed more than 200 patents, employs 300+ professionals (65%+ holding graduate or doctoral degrees), and has cumulatively raised over $100M across multiple funding rounds, with the September 2025 $67M Series D led by Johnson & Johnson Development Corporation marking the most recent capital event. Over 600 clinical surgeries have been completed across multiple specialties with a reported 100% trial success rate. The Yangzhou production base, operational since April 2025, provides designed annual capacity of 500 surgical robot systems and 500,000 surgical instrument sets.

Ronovo Surgical firmographics

Firmographics
Name
Ronovo Surgical
Legal name
瑞龙诺赋(上海)医疗科技有限公司
Website
https://ronovo.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Ronovo Surgical is a Shanghai-based medtech company that develops and commercializes the Haishan-1 modular laparoscopic surgical robot system, serving top-tier hospitals across general surgery, urology, gynecology, and thoracic surgery applications in China and select international markets.
Ownership category
akta.pro rank

Ronovo Surgical industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAE
Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics

Keywords

  • Modular surgical robots
  • Minimally invasive surgery
  • Robotic-assisted surgery
  • Laparoscopic surgical systems
  • Surgical robotics

Where Ronovo Surgical is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Offices3 records

Markets served

Ronovo Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Surgical Robot System Sales: Sale of Haishan-1 modular surgical robot systems to hospitals, including configurable cart quantities and instrument sets
  2. Surgical Instruments and Consumables: Single-use wristed instruments and reusable straight-shaft instruments, with consumable revenue generated per procedure
  3. Clinical Training and Services: Training programs for surgeons and clinical support services through the Yangzhou global production base training center

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Ronovo Surgical product offering

Product offering

Core offering

Ronovo Surgical designs, manufactures, and commercializes the Haishan-1® modular laparoscopic surgical robot system, including its integrated 3D vision platform and surgical instrument portfolio, for sale to hospitals and medical centers. The company's modular split-type architecture enables flexible cart-based deployment of robotic arms across operating rooms, supporting minimally invasive procedures in general surgery, urology, gynecology, and thoracic surgery. Revenue is generated through system sales, recurring consumables (instruments), and clinical training services.

Product overview

Ronovo Surgical offers a modular, platform-based product portfolio centered on the Haishan-1® modular laparoscopic surgical robot system. The core platform consists of independently deployable modular trolleys with robotic arms that can be flexibly configured (3–5 arms) per surgical specialty and procedure type, combined with a surgeon console, electronic hub, and instrument accessories. The product line is supplemented by the Haishan-1® laparoscopic vision system (integrating 4K 3D and ICG fluorescence imaging) and a suite of surgical instruments including wristed and straight-shaft options. An add-on remote surgery ecosystem enables cross-regional surgical mentoring and tele-operation. Together, these products constitute an integrated, modular surgical robotics platform designed to serve general surgery, thoracic surgery, gynecology, and urology.

Differentiator

Problem solved

Functional benefit

Brands

  • 海山一® (Haishan-1 / Carina™): China's first approved modular/lump-separated (分体式) laparoscopic surgical robot system, cleared for General Surgery, Urology, Gynecology, and Thoracic Surgery. Features modular cart design, flexible arm configuration, and compatibility with both wristed and straight instruments.
  • RISE瑞龙国际临床卓越中心 (Ronovo Institute for Surgical Excellence)
  • Carina™ Platform

Products and services

  • Haishan-1® Modular Laparoscopic Surgical Robot System (海山一®分体式腔镜手术机器人系统) China's first domestically developed modular laparoscopic surgical robot featuring a split, modular architecture that separates robotic arms into independent trolley units, allowing flexible positioning, variable arm counts (3–5 arms), and rapid redeployment across operating rooms. NMPA-approved for general surgery, thoracic surgery, gynecology, and urology, designed for hospitals seeking flexible and cost-effective robotic surgery platforms.
  • Haishan-1® Laparoscopic Vision System (海山一®腔镜视觉系统) Integrated imaging module for the Haishan-1 surgical robot platform, incorporating 4K resolution, 3D stereoscopic visualization, and ICG (indocyanine green) fluorescence imaging with real-time blood flow perfusion assessment, tumor margin analysis, and anatomical structure identification capabilities.
  • Haishan-1® Surgical Instruments (海山一®手术器械) Surgical instrument portfolio for the Haishan-1 platform including wristed instruments (8mm) with enhanced articulation and straight-shaft instruments (5mm) for cost-effective procedures. Compatible with traditional laparoscopic instruments and the modular robotic system; supports multiple surgical disciplines.
  • Ronovo Surgical Remote Surgery Ecosystem (Remote Surgical Assistance Platform) A remote surgery platform enabling remote digital surgical mentoring and tele-surgery capabilities, supporting mentor-guided operation modes and demonstration modes for cross-regional surgical skill transfer, with latency controlled within 20ms over standard broadband networks.

Quantifiable outcome

  • 600+ successful clinical surgeries completed across 5 specialties as of end of 2025
  • +4 more outcomes

Companies that use Ronovo Surgical

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles1 record

Ronovo Surgical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability1 record

Feature5 records

Ronovo Surgical partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered regional, significant and core.

  • Clinica Monterrico, PeruregionalChannel Partner/ Reseller/ Distributor · 29 April 2026First Latin America commercial deployment and training center establishment for Spanish-speaking surgeon training in modular robotic surgery.
  • 大连理工大学医学部 (DUT Medical School)significantStrategic or Co-development Partner · 3 November 2025Industry-education partnership for talent cultivation, clinical research collaboration, and curriculum development related to surgical robotics.
  • Johnson & Johnson MedTech (强生医疗科技)coreStrategic or Co-development Partner · 4 September 2025Strategic collaboration signed September 2025 to combine Ronovo's Haishan-1 modular surgical robot platform with J&J MedTech's minimally invasive surgery expertise. Partnership targets offering comprehensive digital minimally invasive surgery solutions to healthcare institutions in China. This marks J&J's first strategic partnership with a domestic surgical robot company.
  • 扬州大学附属医院 (Yangzhou University Affiliated Hospital)significantStrategic or Co-development Partner · 26 April 2025Strategic cooperation signed for clinical research collaboration, talent development, and promotion of surgical robot clinical applications.
  • AdventHealth Nicholson CentercoreStrategic or Co-development Partner · 19 June 2024Partnership to establish RISE (Ronovo Institute for Surgical Excellence) international clinical research center in Orlando, leveraging AdventHealth's surgical training infrastructure.
  • GE Healthcare China (GE医疗中国)significantStrategic or Co-development Partner · 16 November 2023First batch company to join GE Healthcare's largest 'Innovation Center' in Shanghai Zhangjiang, focusing on digital medical imaging integration with surgical robotics.

Scale indicators7 records

Recent moves10 records

Expansion highlights7 records

Ronovo Surgical competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Global incumbent in robotic-assisted surgery with the da Vinci platform. Direct competitor in laparoscopic/soft-tissue robotic surgery across the same four specialties (general, urology, gynecology, thoracic) that Ronovo targets, with a dominant installed base in tier-1 Chinese hospitals.
  • Medtronic: Global medtech incumbent developing the Hugo robotic-assisted surgery platform. Competes in laparoscopic robotic surgery worldwide and is partnering with Ronovo-adjacent stakeholders, shaping the competitive context for Ronovo's international expansion.
  • Johnson & Johnson MedTech: Strategic partner of Ronovo and a competitor via the Ottava general-surgery robotics platform. The dual relationship creates both a major distribution advantage and a channel-conflict risk for Ronovo's international expansion.
  • Stryker (Mako): Global medtech incumbent with the Mako orthopedic surgical robot and an emerging presence in soft-tissue robotics. Relevant as a broad incumbent in surgical robotics that competes for hospital capital budgets and OR integration contracts.

Direct peers

  • Shurui Robot (术锐机器人): Chinese domestic competitor developing single-port and modular endoscopic surgical robots with NMPA approvals. Targets the same Chinese hospital market and minimally invasive surgery applications as Ronovo's Haishan-1.
  • Edge Medical Robotics (精锋医疗): Chinese surgical robotics company with NMPA-approved laparoscopic and orthopedic robot systems. Competes head-to-head in the Chinese modular/multi-port robotic surgery market against Ronovo.
  • Touch Surgery (Toumai): Chinese laparoscopic surgical robot company with NMPA-cleared systems, commercial deployments in Chinese hospitals, and overlapping specialty indications. Closest direct peer in the China multi-port modular robot category.
  • CMR Surgical: UK-based developer of the Versius modular surgical robot — a small-form-factor, modular-cart design that competes on the same portability, footprint, and cost-flexibility thesis as Ronovo's Haishan-1, targeting global markets.

Emerging players

  • Meere Company (Revo-i): Korean developer of the Revo-i laparoscopic surgical robot with regulatory approvals in multiple countries. Comparable modular-style platform competing for emerging-market and Asian hospital customers in the same specialty segments.
  • Vicarious Surgical: U.S. developer of a next-generation robotic surgery platform using decoupled/portable architecture. Comparable in pursuing a fundamentally different form-factor and deployment model than monolithic incumbents, though still pre-commercial.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Ronovo Surgical social profiles

Digital presence

Ronovo Surgical compliance and trust

Trust signal

Compliance1 record

Ronovo Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ronovo Surgical leadership team

Management profile

Number of profiles

Profiles1 record

Ronovo Surgical subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Ronovo Surgical funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ronovo Surgical M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ronovo Surgical

What does Ronovo Surgical do?

Ronovo Surgical designs, manufactures, and commercializes the Haishan-1® modular laparoscopic surgical robot system, including its integrated 3D vision platform and surgical instrument portfolio, for sale to hospitals and medical centers. The company's modular split-type architecture enables flexible cart-based deployment of robotic arms across operating rooms, supporting minimally invasive procedures in general surgery, urology, gynecology, and thoracic surgery. Revenue is generated through system sales, recurring consumables (instruments), and clinical training services.

Is Ronovo Surgical a public or private company?

Ronovo Surgical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ronovo Surgical founded?

Ronovo Surgical was founded in 2019. It employs 51 to 100 people.

Where is Ronovo Surgical based?

Ronovo Surgical is headquartered in Shanghai, China, in the Asia region.

How does Ronovo Surgical make money?

Three revenue lines are on record. Surgical Robot System Sales are the primary driver. The others are surgical Instruments and Consumables and clinical Training and Services.

Who are Ronovo Surgical's main competitors?

Broad incumbents on record are Intuitive Surgical, Medtronic, Johnson & Johnson MedTech and Stryker (Mako). Direct peers are Shurui Robot (术锐机器人), Edge Medical Robotics (精锋医疗), Touch Surgery (Toumai) and CMR Surgical. Emerging players are Meere Company (Revo-i) and Vicarious Surgical.

Does Ronovo Surgical have an API?

No public API is recorded for Ronovo Surgical.

What industry is Ronovo Surgical in?

Ronovo Surgical's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAE, Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CB InsightsSurgical robots reach an inflection point: Here are the M&A targets leading the shiftIntuitive announced plans to acquire the distribution business for its surgical robots in several European countries, while Johnson & Johnson led a $67M Series D funding round for Shanghai-based Ronovo Surgical and secured distribution rights in parts of China. These moves reflect a broader industry shift as AI and computer vision technologies make surgical robots more precise and versatile across various procedures.AI InsiderRonovo Surgical Closes Series D FinancingRonovo Surgical closed a $67 million Series D financing round led by Johnson & Johnson's JJDC, bringing its 2025 fundraising to over $100 million. The company signed a collaboration with Johnson & Johnson Medical (Shanghai) to expand access to its Carina modular robotic platform in China, which received NMPA approval in March 2025. Global expansion is underway with regulatory submissions in Europe and South America.FinancialContent Business PageRonovo Surgical Closes Series D FinancingRonovo Surgical closed a $67 million Series D financing round led by Johnson & Johnson’s JJDC, bringing its total 2025 funding to over $100 million. The company simultaneously signed a collaboration agreement with Johnson & Johnson Medical (Shanghai) Ltd. to expand access to its Carina™ robotic surgery platform in China. This deal follows the March 2025 regulatory approval of Carina™ in China, marking it as the first modular surgical robotic system approved for four major specialties in the country.SciencedirectNew surgical robotic platforms in China and their applications in urologic surgeriesThis editorial reviews the emergence and clinical applications of new domestic surgical robotic platforms in China, highlighting their role in addressing the high demand and cost barriers associated with the dominant da Vinci system. It details performance data from various multi-port and single-port systems developed by Chinese companies such as Edge Medical, MicroPort MedBot, and Ronovo Surgical, noting that while they show comparable safety and efficacy to established international rivals, they face challenges regarding operational efficiency and long-term stability. The article anticipates that increased competition from these domestic manufacturers will drive down prices and expand access to robot-assisted surgery across the country.YahooRobots in surgery – a clinical trial snapshotThe surgical robotics market is projected to grow from $8.6bn in 2022 to $15.8bn by 2030, with companies like Microbot, Vitestro, J&J, and Ronovo advancing clinical trials. Microbot's Liberty system received FDA clearance, Vitestro's blood-drawing device met its primary endpoint, and J&J plans an IDE application in H2 2024.YahooRobots in surgery – a clinical trial snapshotThe surgical robotics market is projected to grow from $8.6bn in 2022 to $15.8bn by 2030, with companies like Microbot, Vitestro, J&J, and Ronovo advancing clinical trials. Microbot's Liberty system received FDA clearance, Vitestro's blood-drawing device met its primary endpoint, and J&J plans an IDE application in H2 2024.FinSMEsRonovo Surgical Closes $44M Series B Financing to Advance CARINA™ Platform Towards Commercialization and International ExpansionRonovo Surgical closed a $44M Series B round co-led by Guolian Capital and INCE Capital to advance its Carina robotic platform. The company expects NMPA approval in China and commercialization in early 2025, with a new facility and international site in Orlando.PR NewswireRONOVO SURGICAL CLOSES $44M SERIES B FINANCING TO ADVANCE CARINA™ PLATFORM TOWARDS COMMERCIALIZATION AND INTERNATIONAL EXPANSIONRonovo Surgical closed a $44M Series B financing round co-led by Guolian Capital and INCE Capital. The funds will advance commercialization of its Carina robotic platform in China, with NMPA approval expected in early 2025. The company also launched its first international site, the Ronovo Institute of Surgical Excellence in Orlando.MassDeviceRonovo Surgical raises $26M for surgical robot platformRonovo Surgical raised $26 million in its second funding round led by NRL Capital to accelerate the commercialization of its Carina surgical robot platform. The total capital raised since 2020 now exceeds $76 million, supporting the company's progress toward multi-specialty human clinical trials and global expansion. The modular system was developed in collaboration with Chinese surgeons to enhance flexibility and efficiency in minimally invasive surgeries.https://www.avcj.comChina robot surgery specialist raises $27mShanghai-based Ronovo Surgical has raised CNY200m (USD 27m) in an extended pre-Series B funding round led by NRL Capital, with participation from Kington Capital and existing investors. The company plans to use the proceeds for product registration, clinical trials, and R&D to accelerate the commercial launch of its modular Haishan-1 surgical robot. This development supports the scaling of a domestically developed technology aimed at reducing costs for minimally invasive procedures.